Evidence item
The source specifies primary human cells and named genome-engineering applications, bounding the claim’s demonstrated scope. DIRECT_TEXT
Source: Targeted genomic integration and rearrangement using prime assembly · locator {} · excerpt hash sha256:81dad7d25a3f2e70bbb02f92d92272ff3bdcd7ec6e4d02e9286e3a9e673cbc47
Exact excerpt
Here we develop prime assembly, an approach that permits DNA sequence assembly and integration in human cells leveraging CRISPR-targeted dual flap synthesis. This method enables RNA-programmable site-specific integration of single or double-stranded DNA fragments. Unlike homology-directed repair, prime assembly is similarly active in dividing and non-dividing cells. We applied prime assembly to perform targeted exon recoding, transgene integration and megabase-scale rearrangements, including at therapeutically relevant loci in primary human cells. Prime assembly expands the capabilities of genome engineering by enabling the targeted integration of medium to large-sized DNA sequences without relying on double-stranded DNA donors, nuclease-driven double-strand breaks or cell cycle progression.
Linked claims
| Claim | Direction | Relevance | Steps | Counted |
|---|---|---|---|---|
| 0a685248 | QUALIFY | DIRECT | 0 | yes |
Audits
None.